Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G BAMBER

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Proceedings of the Royal Society of Medicine|December 9, 2009
Rosaceous TuberculideG Bamber
Proceedings of the Royal Society of Medicine|December 9, 2009
Connective Tissue NævusG Bamber
BMJ (Clinical Research Ed.)|March 20, 1999
Postmarketing surveillance study of a non-chlorofluorocarbon inhaler. Such studies initiated by manufacturer are designed to promote productM G Bamber
Lancet (London, England)|December 21, 1996
Difficulties with CFC-free salbutamol inhalerM G Bamber
Lancet (London, England)|November 5, 2002
Full routine examination of patientsMichael G Bamber
BMJ (Clinical Research Ed.)|April 15, 2010
Coroners. No morbid anatomists remainMichael G Bamber
Lancet (London, England)|December 4, 1982
Fire hazard of nitroglycerin aerosolM G Bamber
Lancet (London, England)|September 24, 1998
Wernicke's encephalopathyM G Bamber
Proceedings of the Royal Society of Medicine|December 9, 2009
Pigmented EpitheliomaG Bamber, W Freudenthal
Postgraduate Medical Journal|January 1, 1985
Toxic shock: clinical presentation and management. IM G Bamber, P D Welsby
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Proceedings of the Royal Society of Medicine|December 9, 2009
Rosaceous TuberculideG Bamber
Proceedings of the Royal Society of Medicine|December 9, 2009
Connective Tissue NævusG Bamber
BMJ (Clinical Research Ed.)|March 20, 1999
Postmarketing surveillance study of a non-chlorofluorocarbon inhaler. Such studies initiated by manufacturer are designed to promote productM G Bamber
Lancet (London, England)|December 21, 1996
Difficulties with CFC-free salbutamol inhalerM G Bamber
Lancet (London, England)|November 5, 2002
Full routine examination of patientsMichael G Bamber
BMJ (Clinical Research Ed.)|April 15, 2010
Coroners. No morbid anatomists remainMichael G Bamber
Lancet (London, England)|December 4, 1982
Fire hazard of nitroglycerin aerosolM G Bamber
Lancet (London, England)|September 24, 1998
Wernicke's encephalopathyM G Bamber
Proceedings of the Royal Society of Medicine|December 9, 2009
Pigmented EpitheliomaG Bamber, W Freudenthal
Postgraduate Medical Journal|January 1, 1985
Toxic shock: clinical presentation and management. IM G Bamber, P D Welsby
Pageof 5